{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:24:37Z","timestamp":1792034677027,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,24]],"date-time":"2027-02-24T00:00:00Z","timestamp":1803427200000},"content-version":"am","delay-in-days":268,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001017","name":"California Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121423","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:15:24Z","timestamp":1771226124000},"page":"121423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial"],"prefix":"10.1016","volume":"403","author":[{"given":"Marc J.","family":"Weintraub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Jeffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lindsey","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewa","family":"Artin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Salimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Grody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Eales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Miklowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.ajp.20231063","article-title":"Single-dose psilocybin for depression with severe treatment resistance: an open-label trial","volume":"182","author":"Aaronson","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121423_bb0010","series-title":"DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, Text Revision","author":"American Psychiatric Association","year":"2000"},{"issue":"2","key":"10.1016\/j.jad.2026.121423_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0005-7894(04)80036-4","article-title":"Toward a unified treatment for emotional disorders","volume":"35","author":"Barlow","year":"2004","journal-title":"Behav. Ther."},{"issue":"9","key":"10.1016\/j.jad.2026.121423_bb0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jamapsychiatry.2017.2164","article-title":"The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial","volume":"74","author":"Barlow","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.121423_bb0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121423_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/psymed.2023.0007","article-title":"A systematic review of reporting practices in psychedelic clinical trials: psychological support, therapy, and psychosocial interventions","volume":"1","author":"Brennan","year":"2023","journal-title":"Psychedelic Med."},{"issue":"7","key":"10.1016\/j.jad.2026.121423_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.jad.2026.121423_bb0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jad.2026.121423_bb0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tics.2010.06.007","article-title":"Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings","volume":"14","author":"Clark","year":"2010","journal-title":"Trends Cogn. Sci."},{"issue":"10","key":"10.1016\/j.jad.2026.121423_bb0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s44159-024-00355-4","article-title":"Positive affect and reward processing in the treatment of depression, anxiety and trauma","volume":"3","author":"Craske","year":"2024","journal-title":"Nat. Rev. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2026.121423_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.121423_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121423_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jad.2024.09.133","article-title":"Single-dose psilocybin for US military Veterans with severe treatment-resistant depression\u2013a first-in-kind open-label pilot study","volume":"369","author":"Ellis","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121423_bb0070","series-title":"SCID-5-CV: Structured Clinical Interview for DSM-5 Disorders: Clinician Version","author":"First","year":"2016"},{"key":"10.1016\/j.jad.2026.121423_bb0075","series-title":"SCID-5-PD: Structured Clinical Interview for DSM-5 Personality Disorders, VA","author":"First","year":"2016"},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.jad.2026.121423_bb0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S0033291706007355","article-title":"The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples","volume":"36","author":"Fowler","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.121423_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"issue":"18","key":"10.1016\/j.jad.2026.121423_bb0095","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cassist psychotherapy\u201d?","volume":"181","author":"Goodwin","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/B:JOBA.0000007455.08539.94","article-title":"Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale","volume":"26","author":"Gratz","year":"2004","journal-title":"J. Psychopathol. Behav. Assess."},{"key":"10.1016\/j.jad.2026.121423_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.copsyc.2015.02.010","article-title":"Examining emotion regulation as an outcome, mechanism, or target of psychological treatments","volume":"3","author":"Gratz","year":"2015","journal-title":"Curr. Opin. Psychol."},{"issue":"12","key":"10.1016\/j.jad.2026.121423_bb0115","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121423_bb0120","series-title":"Handbook of Medical Hallucinogens","author":"Grob","year":"2021"},{"issue":"2","key":"10.1016\/j.jad.2026.121423_bb0125","first-page":"93","article-title":"Preliminary evidence for the reliability and validity of an abbreviated profile of mood states","volume":"23","author":"Grove","year":"1992","journal-title":"Int. J. Sport Psychol."},{"issue":"2","key":"10.1016\/j.jad.2026.121423_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121423_bb0135","series-title":"Assessment Manual for Psychopharmacology","first-page":"217","article-title":"Clinical global impression","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2026.121423_bb0140","series-title":"Assessment of Depression","first-page":"143","article-title":"The Hamilton Rating Scale for Depression","author":"Hamilton","year":"1986"},{"issue":"4","key":"10.1016\/j.jad.2026.121423_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archpsyc.62.4.417","article-title":"Prevention of relapse following cognitive therapy vs medications in moderate to severe depression","volume":"62","author":"Hollon","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.121423_bb0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jad.2026.121423_bb0160","article-title":"A randomized controlled pilot trial of the unified protocol for transdiagnostic treatment of emotional disorders in children","author":"Kennedy","year":"2018","journal-title":"Behav. Modif."},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1176\/appi.ajp.20230884","article-title":"Compass psychological support model for COMP360 psilocybin treatment of serious mental health conditions","volume":"182","author":"Kirli\u0107","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2026.121423_bb0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.jad.2026.121423_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","article-title":"Client satisfaction questionnaire","volume":"2","author":"Larsen","year":"1979","journal-title":"Eval. Program Plann."},{"key":"10.1016\/j.jad.2026.121423_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcbs.2019.10.003","article-title":"Toward a contextual psychedelic-assisted therapy: perspectives from acceptance and commitment therapy and contextual behavioral science","volume":"14","author":"Luoma","year":"2019","journal-title":"J. Contextual Behav. Sci."},{"issue":"2","key":"10.1016\/j.jad.2026.121423_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121423_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2022.102172","article-title":"Stage models for major depression: cognitive behavior therapy, mechanistic treatment targets, and the prevention of stage transition","volume":"95","author":"Otto","year":"2022","journal-title":"Clin. Psychol. Rev."},{"issue":"12","key":"10.1016\/j.jad.2026.121423_bb0195","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2013Suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2026.121423_bb0200","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.jad.2026.121423_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2026.121423_bb0210","series-title":"Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers, Revised Edition","author":"Schultes","year":"2001"},{"key":"10.1016\/j.jad.2026.121423_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.002","article-title":"Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame","volume":"15","author":"Sloshower","year":"2020","journal-title":"J. Contextual Behav. Sci."},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0220","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial","volume":"14","author":"Sloshower","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2024.01.002","article-title":"Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin","volume":"96","author":"Stoliker","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121423_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.586682","article-title":"Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research","volume":"12","author":"Tai","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.121423_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/2164957X221081113","article-title":"Psychedelic psychotherapy: building wholeness through connection","volume":"11","author":"Vaid","year":"2022","journal-title":"Glob. Adv. Health Med."},{"key":"10.1016\/j.jad.2026.121423_bb0240","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"Eclinicalmedicine"},{"issue":"1","key":"10.1016\/j.jad.2026.121423_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/wps.21170","article-title":"How should psychotherapy proceed when adjoined with psychedelics?","volume":"23","author":"Weintraub","year":"2024","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121423_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/psymed.2023.0018","article-title":"Psilocybin-assisted cognitive behavioral therapy for adults with major depressive disorder: rationale and treatment development","volume":"1","author":"Weintraub","year":"2023","journal-title":"Psychedelic Med."},{"issue":"7","key":"10.1016\/j.jad.2026.121423_bb0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archpsyc.57.7.675","article-title":"Brief screening for family psychiatric history: the family history screen","volume":"57","author":"Weissman","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2026.121423_bb0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother. Psychosom."},{"issue":"5","key":"10.1016\/j.jad.2026.121423_bb0265","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother. Psychosom."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:03:12Z","timestamp":1786035792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726002740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"alternative-id":["S0165032726002740"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121423","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121423"}}